Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Treatment of Unresectable Liver Cancer With Graded Embolization of Uniform-sized Drug-loaded Microspheres Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study

NCT07180459 is registered in ClinicalTrials.gov with Xuhua Duan as lead sponsor.

NCT NCT07180459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Treatment of Unresectable Liver Cancer With Graded Embolization of Uniform-sized Drug-loaded Microspheres Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
Lead sponsor
Xuhua Duan
Phase
Observational
Overall status
Not yet recruiting
Start date
October 10, 2025
Completion date
October 10, 2027
Enrollment
118 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular carcinoma